查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463898

直接面對消費者的基因測試市場 - 全球產業規模、佔有率、趨勢、機會和預測，按測試類型、技術、樣本、配銷通路、地區和競爭細分，2019-2029F

Direct-To-Consumer Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By Sample, By Distribution Channel, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年，全球直接面對消費者(DTC) 基因測試市場估值為15 億美元，預計在預測期內將出現令人印象深刻的成長，到2029 年複合年成長率為8.45%。 (DTC) 基因測試市場是一個充滿活力且快速發展的領域，處於醫療保健和消費者基因組學的交叉點。 DTC 基因檢測涉及個人直接獲取有關自己的遺傳訊息，而無需醫療保健專業人員的參與。

DTC 基因檢測市場的核心是為那些對自己的基因組成及其對健康、血統和性狀的影響感到好奇的個人提供便利。消費者可以在線上訂購檢測試劑盒，在家中接收，提供 DNA 樣本（通常透過唾液），然後將樣本交回給檢測公司。然後該公司分析 DNA，產生有關個人遺傳訊息各個方面的報告。市場的主要驅動力之一是人們對了解健康狀況遺傳傾向的興趣日益濃厚。 DTC 基因檢測公司可深入了解個人罹患某些類型癌症、心血管疾病和遺傳性疾病等疾病的遺傳風險。這些資訊使消費者能夠就他們的生活方式、醫療保健和預防措施做出明智的決定。血統測試已成為一項流行的功能，允許個人探索他們的遺傳遺產並發現有關其家族史的資訊。基因組學的技術進步，特別是 DNA 定序和資料分析的技術進步，在 DTC 基因檢測市場的擴張中進一步發揮了至關重要的作用。基因檢測結果準確性和深度的提高有助於提高市場的可信度和吸引力。

該市場的特點是參與者多元化，包括成熟公司、新創公司和知名消費者基因組品牌。這些公司通常透過提供獨特的功能（例如特定的健康風險評估、詳細的血統報告或特徵分析）來使自己脫穎而出。與研究機構和製藥公司的資料共享和合作研究合作有助於市場的活力。

DTC 基因檢測市場也面臨挑戰和倫理考量。與基因資料處理相關的隱私問題、敏感資訊的潛在濫用以及測試結果的準確性都是受到審查的主題。 DTC 模式中缺乏遺傳諮詢，引發如何向消費者適當解釋和傳達複雜遺傳訊息的問題。

主要市場促進因素

消費者對個人化健康見解的需求

主要市場挑戰

隱私和安全問題

結果的準確性和解釋

監管和道德考慮

遺傳諮詢和知情同意

主要市場趨勢

擴展的測試產品和服務

遠距醫療和遠距諮詢

細分市場洞察

測試類型見解

技術洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球直接面對消費者 (DTC) 基因檢測市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 依測試類型（祖先關係測試、預測測試、營養基因組測試、攜帶者測試、護膚測試等）
    • 依技術（單核苷酸多態性（SP）晶片、標靶分析、全基因組定序（WGS）、其他）
    • 依樣本（唾液、尿液、血液、其他）
    • 依配銷通路（線上、線下）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖

第 5 章：亞太地區直接面對消費者 (DTC) 基因檢測市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按測試類型
    • 依技術
    • 按樣品
    • 按配銷通路
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第 6 章：歐洲直接面對消費者 (DTC) 基因檢測市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按測試類型
    • 依技術
    • 按樣品
    • 按配銷通路
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美直接面對消費者 (DTC) 基因檢測市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按測試類型
    • 依技術
    • 按樣品
    • 按配銷通路
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美洲直接面對消費者 (DTC) 基因檢測市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按測試類型
    • 依技術
    • 按樣品
    • 按配銷通路
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲直接面對消費者 (DTC) 基因檢測市場展望

  • 市場規模預測
    • 按價值
  • 市佔率預測
    • 按測試類型
    • 依技術
    • 按樣品
    • 按配銷通路
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢發展

  • 最近的發展
  • 產品發布
  • 併購

第 12 章：全球直接面對消費者 (DTC) 基因檢測市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • andMe, Inc
  • Ancestry.com, LLC
  • Color Health, Inc
  • Helix, Inc.
  • Counsyl, Inc.
  • MyHeritage Ltd.
  • Living DNA Ltd.
  • Mapmygenome India Limited
  • Full Genomes Corporation, Inc
  • Direct Laboratory Services, LLC

第 15 章：策略建議

第 16 章：關於我們免責聲明

簡介目錄
Product Code: 12949

Global Direct-To-Consumer (DTC) Genetic Testing Market wasvalued at USD 1.50 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.45% through 2029. The Direct-to-Consumer (DTC) Genetic Testing Market is a dynamic and rapidly evolving sector at the intersection of healthcare and consumer genomics. DTC genetic testing involves individuals directly accessing genetic information about themselves without the involvement of healthcare professionals.

At the core of the DTC Genetic Testing Market is the accessibility it offers to individuals who are curious about their genetic makeup and its implications for health, ancestry, and traits. Consumers can order testing kits online, receive them at home, provide a DNA sample (usually through saliva), and return the sample to the testing company. The company then analyzes the DNA to generate reports on various aspects of the individual's genetic information. One of the key drivers of the market is the rising interest in understanding one's genetic predispositions for health conditions. DTC genetic testing companies provide insights into an individual's genetic risk for conditions such as certain types of cancer, cardiovascular diseases, and hereditary conditions. This information empowers consumers to make informed decisions about their lifestyle, healthcare, and preventive measures. Ancestry testing has become a popular feature, allowing individuals to explore their genetic heritage and discover information about their family history. Technological advancements in genomics, particularly in DNA sequencing and data analysis, have further played a crucial role in the expansion of the DTC Genetic Testing Market. Improvements in the accuracy and depth of genetic testing results contribute to the market's credibility and appeal.

The market is characterized by a diverse range of players, including established companies, startups, and well-known consumer genomics brands. These companies often differentiate themselves by offering unique features such as specific health risk assessments, detailed ancestry reports, or traits analysis. Partnerships with research institutions and pharmaceutical companies for data sharing and collaborative studies contribute to the market's dynamism.

The DTC Genetic Testing Market also faces challenges and ethical considerations. Privacy concerns related to the handling of genetic data, the potential misuse of sensitive information, and the accuracy of test results are subjects of scrutiny. The lack of genetic counseling in the DTC model raises questions about the appropriate interpretation and communication of complex genetic information to consumers.

Key Market Drivers

Consumer Demand for Personalized Health Insights

Consumer demand for personalized health insights stands as the driving force behind the rapid growth and evolution of the Direct-to-Consumer (DTC) Genetic Testing Market. This demand reflects a paradigm shift in healthcare, where individuals are increasingly taking proactive steps to gain a deeper understanding of their genetic makeup and its implications for their well-being. At the core of this driver is the human desire for knowledge-specifically, knowledge about one's own genetic information and its potential impact on health. People are inherently curious about their predispositions to various health conditions, the likelihood of developing certain diseases, and insights into their overall genetic health profile. DTC genetic testing addresses this curiosity by providing individuals direct access to information encoded in their DNA without the need for intermediary healthcare professionals.

The appeal of personalized health insights lies in the empowerment it offers to consumers. Armed with knowledge about their genetic risk factors, individuals can make informed decisions about their lifestyle, health management, and preventive measures. For instance, if a person learns about a heightened genetic susceptibility to a specific condition, they may choose to adopt lifestyle changes, undergo more frequent screenings, or consult with healthcare professionals for targeted preventive strategies. The growing emphasis on preventive healthcare aligns with the demand for personalized genetic insights. Consumers recognize that understanding their genetic predispositions allows for early intervention and proactive measures to mitigate potential health risks. This shift toward a preventive healthcare mindset is reshaping the healthcare landscape, with individuals seeking to leverage genetic information to optimize their health and well-being.

The COVID-19 pandemic has further highlighted the importance of accessible and convenient healthcare services. With lockdowns and restrictions limiting physical interactions, consumers turned to DTC genetic testing as a viable option for gaining health insights from the safety of their homes. The pandemic accelerated the adoption of remote healthcare solutions, and DTC genetic testing emerged as a resilient and adaptable option for individuals seeking health information during challenging times.

Key Market Challenges

Privacy and Security Concerns

Privacy and security concerns pose significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The inherent sensitivity of genetic data raises fears about potential breaches, unauthorized access, and misuse. Consumers worry about the protection of their most personal information. Safeguarding genetic data against cyber threats and ensuring compliance with data protection regulations are paramount. Companies in the DTC genetic testing space must invest in robust security measures, transparent privacy policies, and clear communication to build and maintain consumer trust. Addressing these concerns is essential for the sustainable growth of the market and fostering a secure environment for individuals to explore their genetic information.

Accuracy and Interpretation of Results

The challenge of accuracy and interpretation of results in the Direct-to-Consumer (DTC) Genetic Testing Market stems from the complexity of genetic data and the evolving nature of scientific knowledge. Variability in testing methodologies can lead to discrepancies, and the intricate nature of genetic information demands precision. Ensuring that consumers receive reliable and meaningful insights requires continuous efforts to enhance testing accuracy and improve result interpretation. Striking a balance between providing comprehensive genetic information and maintaining precision is essential to address this challenge and instill confidence in consumers regarding the reliability of their DTC genetic testing outcomes.

Regulatory and Ethical Considerations

Regulatory and ethical considerations pose significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The dynamic regulatory landscape requires companies to navigate evolving frameworks while ensuring compliance and innovation. Ethical concerns revolve around responsible use of genetic information, potential psychological impacts on consumers, and the need for informed consent. Striking a balance between promoting innovation, protecting consumers, and upholding ethical standards is a delicate challenge. Companies must actively engage in transparent communication, adhere to evolving regulatory requirements, and establish ethical guidelines to address these challenges and foster a trustworthy environment for consumers exploring DTC genetic testing services.

Genetic Counseling and Informed Consent

Genetic counseling and obtaining informed consent present significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The absence of direct, in-person genetic counseling within the DTC model raises concerns regarding consumers' capacity to comprehend intricate genetic information and the potential health implications. Ensuring sufficient support and securing informed consent emerge as critical obstacles, particularly given the nuanced nature of genetic data. Balancing accessibility with the necessity for comprehensive understanding presents a formidable challenge. Addressing this challenge entails developing effective methods for providing genetic counseling remotely, thereby empowering consumers with the knowledge required to make informed decisions about their health based on the results of DTC genetic testing.

Key Market Trends

Expanded Test Offerings and Services

The trend of expanded test offerings and services in the Direct-to-Consumer (DTC) Genetic Testing Market signifies a shift beyond traditional health-related insights. Companies are diversifying their portfolios to include a broader range of genetic tests, such as ancestry testing, trait analysis, and wellness assessments. This expansion provides consumers with a more comprehensive understanding of their genetic makeup, catering to diverse interests and preferences. By offering a spectrum of tests, DTC genetic testing services aim to engage a wider audience and meet the evolving demands of consumers who seek a holistic view of their genetic information, extending beyond medical implications to encompass various aspects of personal identity and well-being.

Telehealth and Remote Counseling

The trend of telehealth and remote counseling is gaining prominence in the Direct-to-Consumer (DTC) Genetic Testing Market, addressing the challenge of genetic counseling accessibility. Companies are leveraging digital platforms to provide consumers with convenient access to genetic counseling services remotely. This ensures that individuals receive guidance and support in interpreting complex genetic test results from the comfort of their homes. The integration of telehealth not only enhances the overall consumer experience but also promotes informed decision-making. By embracing remote counseling, DTC genetic testing services are bridging the gap between consumers and genetic expertise, making genetic information more accessible and understandable.

Segmental Insights

Test Type Insights

Basedon the test type, ancestry and relationship testing emerged as the fastest growing segment in the Global Direct-to-Consumer (DTC) Genetic Testing Market due to its broad consumer appeal and non-medical nature. This category provides insights into one's heritage, family origins, and connections with relatives, appealing to a diverse consumer base interested in exploring their ancestral roots. The allure of genealogy, family history, and discovering genetic relatives greatly fuels the popularity of Ancestry and Relationship Testing. This non-clinical emphasis aligns with the increasing trend of consumers seeking a comprehensive understanding of their genetic makeup beyond health-related aspects, making it a significantly growing and widely embraced segment in the DTC genetic testing industry.

Technology Insights

Single Nucleotide Polymorphism (SNP) chips dominate the Global Direct-to-Consumer (DTC) Genetic Testing Market due to their efficiency in providing comprehensive genetic insights at an affordable cost. These chips analyze variations in single nucleotides across the genome, offering a cost-effective method for identifying genetic markers associated with various traits, ancestry, and health conditions. The widespread use of SNP chips enables large-scale genotyping, facilitating the generation of extensive genetic data for consumers. This dominance is driven by the balance of accuracy, affordability, and the ability to cover a broad spectrum of genetic information, making SNP chips a preferred choice in the DTC genetic testing landscape.

Regional Insights

North America asserts its dominance in the Global Direct-to-Consumer (DTC) Genetic Testing Market owing to factors such as widespread consumer awareness, favorable regulatory environments, and a robust healthcare infrastructure. The region's tech-savvy population and high disposable income significantly contribute to its substantial market share, as consumers increasingly seek personalized genetic insights. The presence of key market players, active promotion of DTC genetic testing services, and a culture of early technology adoption further bolster North America's leadership position. Collaborative efforts between DTC genetic testing companies and research institutions also enhance the region's status as a hub for genetic testing innovations and advancements.

Key Market Players

23andMe, Inc

Ancestry.com, LLC

Color Health, Inc

Helix, Inc.

Counsyl, Inc.

MyHeritage Ltd.

Living DNA Ltd.

Mapmygenome India Limited

Full Genomes Corporation, Inc

Direct Laboratory Services, LLC

Report Scope:

In this report, the Global Direct-To-Consumer (DTC) Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Direct-To-Consumer (DTC) Genetic Testing Market,By Test Type:

  • Ancestry Relationship Testing
  • Predictive Testing
  • Nutrigenomic Testing
  • Carrier Testing
  • Skincare Testing
  • Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Technology:

  • Single Nucleotide Polymorphism (SP) chips
  • Targeted Analysis
  • Whole Genome Sequencing (WGS)
  • Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Sample:

  • Saliva
  • Urine
  • Blood
  • Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Distribution Channel:

  • Online
  • Offline

Direct-To-Consumer (DTC) Genetic Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Direct-To-Consumer (DTC) Genetic Testing Market.

Available Customizations:

Global Direct-To-Consumer (DTC) Genetic Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Direct-To-Consumer (DTC) Genetic Testing Market Outlook

  • 4.1.Market Size Forecast
    • 4.1.1.By Value
  • 4.2.Market Share Forecast
    • 4.2.1.By Test Type (Ancestry Relationship Testing, Predictive Testing, Nutrigenomic Testing, Carrier Testing, Skincare Testing, Others)
    • 4.2.2.By Technology (Single Nucleotide Polymorphism (SP) chips, Targeted Analysis, Whole Genome Sequencing (WGS), Others)
    • 4.2.3.By Sample (Saliva, Urine, Blood, Others)
    • 4.2.4.By Distribution Channel (Online, Offline)
    • 4.2.5.By Region
    • 4.2.6.By Company (2023)
  • 4.3.Market Map

5.Asia Pacific Direct-To-Consumer (DTC) Genetic Testing Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Test Type
    • 5.2.2.By Technology
    • 5.2.3.By Sample
    • 5.2.4.By Distribution Channel
    • 5.2.5.By Country
  • 5.3.Asia Pacific: Country Analysis
    • 5.3.1.China Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 5.3.1.1.Market Size Forecast
        • 5.3.1.1.1.By Value
      • 5.3.1.2.Market Share Forecast
        • 5.3.1.2.1.By Test Type
        • 5.3.1.2.2.By Technology
        • 5.3.1.2.3.By Sample
        • 5.3.1.2.4.By Distribution Channel
    • 5.3.2.India Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 5.3.2.1.Market Size Forecast
        • 5.3.2.1.1.By Value
      • 5.3.2.2.Market Share Forecast
        • 5.3.2.2.1.By Test Type
        • 5.3.2.2.2.By Technology
        • 5.3.2.2.3.By Sample
        • 5.3.2.2.4.By Distribution Channel
    • 5.3.3.Australia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 5.3.3.1.Market Size Forecast
        • 5.3.3.1.1.By Value
      • 5.3.3.2.Market Share Forecast
        • 5.3.3.2.1.By Test Type
        • 5.3.3.2.2.By Technology
        • 5.3.3.2.3.By Sample
        • 5.3.3.2.4.By Distribution Channel
    • 5.3.4.Japan Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 5.3.4.1.Market Size Forecast
        • 5.3.4.1.1.By Value
      • 5.3.4.2.Market Share Forecast
        • 5.3.4.2.1.By Test Type
        • 5.3.4.2.2.By Technology
        • 5.3.4.2.3.By Sample
        • 5.3.4.2.4.By Distribution Channel
    • 5.3.5.South Korea Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 5.3.5.1.Market Size Forecast
        • 5.3.5.1.1.By Value
      • 5.3.5.2.Market Share Forecast
        • 5.3.5.2.1.By Test Type
        • 5.3.5.2.2.By Technology
        • 5.3.5.2.3.By Sample
        • 5.3.5.2.4.By Distribution Channel

6.Europe Direct-To-Consumer (DTC) Genetic Testing Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Test Type
    • 6.2.2.By Technology
    • 6.2.3.By Sample
    • 6.2.4.By Distribution Channel
    • 6.2.5.By Country
  • 6.3.Europe: Country Analysis
    • 6.3.1.France Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Test Type
        • 6.3.1.2.2.By Technology
        • 6.3.1.2.3.By Sample
        • 6.3.1.2.4.By Distribution Channel
    • 6.3.2.Germany Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Test Type
        • 6.3.2.2.2.By Technology
        • 6.3.2.2.3.By Sample
        • 6.3.2.2.4.By Distribution Channel
    • 6.3.3.Spain Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Test Type
        • 6.3.3.2.2.By Technology
        • 6.3.3.2.3.By Sample
        • 6.3.3.2.4.By Distribution Channel
    • 6.3.4.Italy Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 6.3.4.1.Market Size Forecast
        • 6.3.4.1.1.By Value
      • 6.3.4.2.Market Share Forecast
        • 6.3.4.2.1.By Test Type
        • 6.3.4.2.2.By Technology
        • 6.3.4.2.3.By Sample
        • 6.3.4.2.4.By Distribution Channel
    • 6.3.5.United Kingdom Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 6.3.5.1.Market Size Forecast
        • 6.3.5.1.1.By Value
      • 6.3.5.2.Market Share Forecast
        • 6.3.5.2.1.By Test Type
        • 6.3.5.2.2.By Technology
        • 6.3.5.2.3.By Sample
        • 6.3.5.2.4.By Distribution Channel

7.North America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Test Type
    • 7.2.2.By Technology
    • 7.2.3.By Sample
    • 7.2.4.By Distribution Channel
    • 7.2.5.By Country
  • 7.3.North America: Country Analysis
    • 7.3.1.United States Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Test Type
        • 7.3.1.2.2.By Technology
        • 7.3.1.2.3.By Sample
        • 7.3.1.2.4.By Distribution Channel
    • 7.3.2.Mexico Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Test Type
        • 7.3.2.2.2.By Technology
        • 7.3.2.2.3.By Sample
        • 7.3.2.2.4.By Distribution Channel
    • 7.3.3.Canada Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Test Type
        • 7.3.3.2.2.By Technology
        • 7.3.3.2.3.By Sample
        • 7.3.3.2.4.By Distribution Channel

8.South America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Test Type
    • 8.2.2.By Technology
    • 8.2.3.By Sample
    • 8.2.4.By Distribution Channel
    • 8.2.5.By Country
  • 8.3.South America: Country Analysis
    • 8.3.1.Brazil Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Test Type
        • 8.3.1.2.2.By Technology
        • 8.3.1.2.3.By Sample
        • 8.3.1.2.4.By Distribution Channel
    • 8.3.2.Argentina Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Test Type
        • 8.3.2.2.2.By Technology
        • 8.3.2.2.3.By Sample
        • 8.3.2.2.4.By Distribution Channel
    • 8.3.3.Colombia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Test Type
        • 8.3.3.2.2.By Technology
        • 8.3.3.2.3.By Sample
        • 8.3.3.2.4.By Distribution Channel

9.Middle East and Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Test Type
    • 9.2.2.By Technology
    • 9.2.3.By Sample
    • 9.2.4.By Distribution Channel
    • 9.2.5.By Country
  • 9.3.MEA: Country Analysis
    • 9.3.1.South Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Test Type
        • 9.3.1.2.2.By Technology
        • 9.3.1.2.3.By Sample
        • 9.3.1.2.4.By Distribution Channel
    • 9.3.2.Saudi Arabia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Test Type
        • 9.3.2.2.2.By Technology
        • 9.3.2.2.3.By Sample
        • 9.3.2.2.4.By Distribution Channel
    • 9.3.3.UAE Direct-To-Consumer (DTC) Genetic Testing Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Test Type
        • 9.3.3.2.2.By Technology
        • 9.3.3.2.3.By Sample
        • 9.3.3.2.4.By Distribution Channel

10.Market Dynamics

  • 10.1.Drivers
  • 10.2.Challenges

11.Market Trends Developments

  • 11.1.Recent Developments
  • 11.2.Product Launches
  • 11.3.Mergers Acquisitions

12.Global Direct-To-Consumer (DTC) Genetic Testing Market: SWOT Analysis

13.Porter's Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Product

14.Competitive Landscape

  • 14.1.23andMe, Inc
    • 14.1.1.Business Overview
    • 14.1.2.Company Snapshot
    • 14.1.3.Products Services
    • 14.1.4.Financials (As Reported)
    • 14.1.5.Recent Developments
  • 14.2.Ancestry.com, LLC
  • 14.3.Color Health, Inc
  • 14.4.Helix, Inc.
  • 14.5.Counsyl, Inc.
  • 14.6.MyHeritage Ltd.
  • 14.7.Living DNA Ltd.
  • 14.8.Mapmygenome India Limited
  • 14.9.Full Genomes Corporation, Inc
  • 14.10.Direct Laboratory Services, LLC

15.Strategic Recommendations

16.About Us Disclaimer